Gsk Share Discussion Threads

[essentialinvestor] 25/10/2017 15:02

Hi Phil, would think it was not the best day to report with FX.
Fat FX move may have helped the fall.

SHP Friday from memory, not brave enough to hold any Shire atm.

[tradermichael] 25/10/2017 15:00

Disappointing price performance on the run to the results this week (70p in the day so far !!!!!??) .... still, more than happy to qualify for another fat dividend in 2 weeks time ...... ;0)

[mj19] 25/10/2017 14:59

I did say there was a wave 5 coming lower than the last low

[jadeticl3] 25/10/2017 14:58

I too am surprised at the severity of the fall. I have too many of these to buy more, but will reserve judgement of market reaction until Friday close. Initial reaction is not always a considered response.

[philanderer] 25/10/2017 14:49

Afternoon EI , nothing really surprising in that report for me . Quite surprised at such a negative reaction. Sitting on my hands at the moment :-)

[montyhedge] 25/10/2017 14:49

Ess
I knew you could not resist, lol.

[essentialinvestor] 25/10/2017 14:47

Phil, £14 would not be a surprise.

[essentialinvestor] 25/10/2017 14:44

A few more 1435, Thought the market would not like the report,

[philanderer] 25/10/2017 14:41

Getting dumped at a rate.....Chartwise looking at 1400p support

[essentialinvestor] 25/10/2017 14:39

Very Small amount 1438.

[montyhedge] 25/10/2017 14:37

Yanks must be selling, dropped after 2.30pm.

[philanderer] 25/10/2017 14:36

Bang on chart support.

[spcecks] 25/10/2017 14:08

Also added.

[ny boy] 25/10/2017 14:02

In for that dip!

[montyhedge] 25/10/2017 13:30

Cable is going to 1.35 in my view.

[essentialinvestor] 25/10/2017 13:27

Have to disagree. Net debt continues to increase, payout uncovered.

On cable they are taking 1.28. as of today that is over 1.32.

[spcecks] 25/10/2017 13:20

Rns reads fine to me happy to hold and add on weakness.

[toffeeman] 25/10/2017 13:14

No - but don't worry it'll soon be Xmas.

Vaccines are too cheap

[essentialinvestor] 25/10/2017 13:05

Divdend still appears uncovered by FCF.

Anyone seeing that differently?.

[montyhedge] 25/10/2017 12:45

This trades like a bond, dividend always the same, but with more risk than the GSK Corporate bonds, lol.

[romeike] 25/10/2017 12:26

Probably worth reminding people here that in terms of medical practices and available medicines the UK and Europe generally remain several years behind the US and Japan. And yet the US still likes to moan about paying the slight premium that results in that situation.

[essentialinvestor] 25/10/2017 12:20

Had a quick look and unless I'm misreading, FCF looks on the weak side.
So much detail very difficult to form a view quickly, at least for me!.

[zho] 25/10/2017 12:02

Q3 results out:

Emma Walmsley, Chief Executive Officer, GSK said:
"Performance in the quarter showed continued progress
with sales growth and improved operating margins.
This was driven by targeted cost savings and restructuring
and integration benefits, which particularly benefited
Vaccines and Consumer Healthcare, and also supported
investment in our new products and R&D pipeline.
Adjusted earnings per share for Q3 were 32.5p and
we remain on course for our full-year earnings guidance,
with cash generation continuing to improve. We are
also pleased that we have secured major approvals
for Trelegy Ellipta in COPD and Shingrix, our shingles
vaccine."

[tompion] 25/10/2017 10:11

I also had Zostavax recently which isn't as good - a lower percentage of vaccinated individuals are protected by Zostavax compared to Shingrix.